{
    "title": "Eli Lilly Alzheimer's drug setback extends rival Biogen's lead - analysts",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11658015/Eli-Lilly-Alzheimers-drug-setback-extends-rival-Biogens-lead--analysts.html",
    "date": "2023-01-20",
    "keywords": [
        "drug",
        "approval",
        "market",
        "fda",
        "donanemab",
        "analyst",
        "health",
        "lead",
        "drugmaker",
        "biogen",
        "skorney",
        "jan",
        "rejection",
        "treatment",
        "food",
        "administration",
        "year",
        "thursday",
        "michael",
        "premarket",
        "trading",
        "lillys",
        "inability",
        "launch",
        "postfull",
        "ability",
        "setback",
        "inc",
        "co",
        "ltds",
        "leqembi",
        "insurance",
        "coverage",
        "minimum",
        "time",
        "latestage",
        "trial",
        "quarter",
        "basis",
        "application",
        "anything",
        "reporting",
        "khushi",
        "mandowara",
        "bengaluru",
        "editing",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}